Kidney Sodium Content in Cardiorenal Patients

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

February 28, 2026

Conditions
Cardio-Renal Syndrome
Interventions
DRUG

Furosemide Injection

"We will measure kidney sodium content in patient with cardiorenal syndrome. we will inject within the week of this first measurement furosemide only in patient who will be resistant to diuretics (Based on these parameters, diuretic response will be defined as:~* A reduction in fractional spot urinary sodium~* An increase in urinary volume~* A \>1 kg reduction in body weight within 24 hours from diuretic administration (extrapolation of guidance on management of acute HF) and we will do another measurement of kidney sodium content after furosemide injection."

Trial Locations (1)

Ontario

RECRUITING

"Heart Failure Clinic , St. Joseph's Health Care London"

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER